[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group].
García-Sanz
Ramón
R
Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, España. rgarcias@usal.es
Alegre
Adrián
A
Capote
Francisco Javier
FJ
Hernández
José Mariano
JM
Rosiñol
Laura
L
Rubia
Javier de la
Jde L
Sureda
Anna
A
Arriba
Felipe de
Fd
Bargay
Joan
J
Díaz Mediavilla
Joaquín
J
García-Laraña
José
J
Lahuerta
Juan José
JJ
Mateos
María Victoria
MV
Prósper
Felipe
F
San Miguel
Jesús
J
Bladé
Joan
J
D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications*
D004164:Diphosphonates